טוען...
Current pharmacological treatments for SARS-COV-2: A narrative review
The novel coronavirus, later identified as SARS-CoV-2, originating from Wuhan in China in November 2019, quickly spread around the world becoming a pandemic. Despite the knowledge of previous coronaviruses, such as those responsible for the SARS and MERS-CoV epidemic, there is no drug or prophylaxis...
שמור ב:
| הוצא לאור ב: | Eur J Pharmacol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier B.V.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7320862/ https://ncbi.nlm.nih.gov/pubmed/32603692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2020.173328 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|